Comparison Overview

Zaans Medisch Centrum

VS

Medicover

Zaans Medisch Centrum

Koningin Julianaplein 58 Zaandam, Noord-Holland 1502 DV, NL
Last Update: 2025-03-14 (UTC)

Strong

We zijn een menselijk, sfeervol Zaans ziekenhuis. Het Zaans Medisch Centrum is hét ziekenhuis voor de inwoners van Zaanstad en wijde omgeving. Al meer dan 100 jaar staan wij u bij met goede medische zorg. Zowel in de mooie momenten van het leven, bijvoorbeeld bij een geboorte, als in moeilijke tijden van ziek zijn.

NAICS: 62
NAICS Definition:
Employees: 1,001-5,000
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Medicover

Riddargatan 12A Stockholm, SE-114 83, SE
Last Update: 2025-03-15 (UTC)

Strong

Between 800 and 900

Medicover is a leading international healthcare and diagnostic services provider, headquartered in Sweden and listed on Nasdaq Stockholm. Established in 1995 in response to the growing demand for high-quality healthcare services in Poland, Medicover subsequently expanded to other countries, fulfilling similar needs. Today, Medicover’s largest operations are in Poland, Germany, Romania, India and Ukraine. Medicover provides a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, laboratories, and blood-drawing points through two divisions – Healthcare Services and Diagnostic Services. Healthcare Services – offers high-quality care based on preventive and outpatient care services, specialist healthcare, fertility treatment, state-of-the-art dental services and optician services as well as wellbeing solutions – including sports packages and diets. Care is offered in 9 countries via 182 medical centres, 42 pharmacies, 42 hospitals, 115 dental centres, 39 optical showrooms, 14 mental health centres, 18 fertility clinics and 140 fitness clubs and gyms. The major markets are Poland, India and Romania. Diagnostic Services – offers a broad spectrum of clinical laboratory services including a broad array of laboratory tests in all major clinical pathology areas, ranging from routine to advanced tests and from prevention to monitoring of treatments. The business is conducted through a network of 117 laboratories, 905 blood-drawing points and 31 clinics in 13 countries. The major markets are Germany, Romania, Poland and Ukraine (before the outbreak of war). For more information, visit: https://www.medicover.com/

NAICS: 62
NAICS Definition:
Employees: 10,001+
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/zaans-medisch-centrum.jpeg
Zaans Medisch Centrum
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/medicover.jpeg
Medicover
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
Compliance Summary
Zaans Medisch Centrum
100%
Compliance Rate
0/4 Standards Verified
Medicover
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Zaans Medisch Centrum in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Medicover in 2025.

Incident History — Zaans Medisch Centrum (X = Date, Y = Severity)

Zaans Medisch Centrum cyber incidents detection timeline including parent company and subsidiaries

Incident History — Medicover (X = Date, Y = Severity)

Medicover cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/zaans-medisch-centrum.jpeg
Zaans Medisch Centrum
Incidents

No Incident

https://images.rankiteo.com/companyimages/medicover.jpeg
Medicover
Incidents

No Incident

FAQ

Both Zaans Medisch Centrum company and Medicover company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, Medicover company has disclosed a higher number of cyber incidents compared to Zaans Medisch Centrum company.

In the current year, Medicover company and Zaans Medisch Centrum company have not reported any cyber incidents.

Neither Medicover company nor Zaans Medisch Centrum company has reported experiencing a ransomware attack publicly.

Neither Medicover company nor Zaans Medisch Centrum company has reported experiencing a data breach publicly.

Neither Medicover company nor Zaans Medisch Centrum company has reported experiencing targeted cyberattacks publicly.

Neither Zaans Medisch Centrum company nor Medicover company has reported experiencing or disclosing vulnerabilities publicly.

Neither Zaans Medisch Centrum company nor Medicover company has publicly disclosed detailed information about the number of their subsidiaries.

Neither Zaans Medisch Centrum company nor Medicover company has publicly disclosed the exact number of their employees.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X